DIA is a global association that mobilizes life science professionals from across all areas of expertise to engage with patients, peers and thought leaders in a neutral environment on the issues of today and the possibilities for tomorrow.
As a member-driven volunteer organization, professionals from more than 80 countries have engaged with DIA through our unparalleled membership network, educational offerings, and professional development opportunities.
To keep you at the forefront, DIA offers face-to-face, and online courses (including eLearning programs), certificate programs, and can provide learning for groups at your organization.
The world of healthcare is constantly changing. DIA events will help you stay on top of those changes. At DIA events, key stakeholders from multiple disciplines come together to share information and insights. New perspectives are explored. Career-enhancing relationships are nurtured.
Australian Clinical Trials Alliance Part 2 – Future Projections March 27, 2023 8:36am
“Healthcare systems obviously have as their primary role the delivery of healthcare,” says Steve Webb, Australian Clinical Trials Alliance board chair. “But we can see big improvements in health outcomes, combined with substantially better financial performance of the healthcare system, if the healthcare system has the dual role of treating patients as well as generating evidence about the most effective treatment options to guide that care.”
View this post
ANVISA Explains Innovative Online Optimized Assessment Project March 14, 2023 9:52am
For regulators in Brazil, the pandemic’s aftermath includes a backlog of post-approval changes, delayed by emergency development of COVID-19 vaccines and therapies, related to biologic product quality. ANVISA’s new Online Optimized Assessment Project has significantly resolved these pending requests. “The pandemic had already enabled use of online tools for remote assessment of applications and virtual meetings between ANVISA and applicants, and also helped us be closer to other reference...
View this post
Australian Clinical Trials Alliance Part 1 – Current Perceptions March 6, 2023 2:26pm
“The pandemic had a substantial impact on community understanding of clinical trials. Having said that, the sort of ambient level of community knowledge of clinical trials is still substantially lower than it needs to be,” explains Australian Clinical Trials Alliance Board Chair Steve Webb. “Community awareness of the difference between evaluation of experimental interventions, about which relatively little is known regarding safety and effectiveness, compared with comparative effectivenes...
View this post
Looking Back and Ahead: Translational Science Advances Impacting Patient Care December 19, 2022 3:25pm
From microphysiological systems and digital pathology to next-generation-sequencing and diversity in foundational genomic data sets: In this iteration of our annual year in review podcast, Global Forum Co-Editors for Translational Science Gary Kelloff and Lanny Kirsch discuss emergent technologies and approaches that are upending clinical development, diagnostic, and patient care in oncology and beyond.
View this post
Rwanda Welcomes African Medicines Agency Home November 30, 2022 8:27am
While the African Medicines Agency (AMA) plans and plants its inaugural headquarters in Rwanda, the European Commission, the European Medicines Agency (EMA), several EU Member States, and the Bill and Melinda Gates Foundation continue to mobilize more than €100 million in support. “The idea is to use the AMA as a platform that will further advance the capacities of the African continent to regulate medical products as a collective. It's a network approach to regulation of medical products on...
View this post
Will Technology Solve the Research “People Problem”? November 22, 2022 3:53pm
Clinical trials struggle to enroll eligible patients, while interested patients have difficulty finding pertinent clinical trials. Can technology help solve this people problem? “Typical patient recruitment happens based on historical data at research sites and that usually does not help, given the number of competing clinical trials trying to reach out to the same patients,” explains Indegene Senior Vice President for Enterprise Clinical Solutions Ram Yeleswarapu. “But today, tools and te...
View this post
Head of Strategic Partnerships
DIA Global
Washington, District of Columbia
